Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment - Sanchez-Tapias, J M; Diago, M; Escartin, P (Gastroenterology, 2006)
et al.